Chronic periodontitis as a risk marker for systemic diseases with reference to cardiometabolic disorders: Common pathways in their progression

Immunology and Immunogenetics Insights

Volumn 2, Issue 1, 2010, Pages 7-21

  Soory, Mena ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiometabolic disease; Cytokines; Dyslipidaemia; Periodontitis; Risk markers

Indexed keywords

EID: 80051490224     PISSN: None     EISSN: 11786345     Source Type: Journal    
DOI: 10.4137/iii.s5795     Document Type: Review

References (136)

1. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid- based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci. 2007;1098(1): 230-51.
2. Chapple IL, Matthews JB. The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43(1):160-232.
3. Paquette DW, Brodala N, Nichols TC. Cardiovascular disease, inflammation, and periodontal infection. Periodontol 2000. 2007;44(1):113-26.
4. Fardi A, Papadimitriou D. Periodontal and atherosclerosis-induced diseases. Int Angiol. 2007;26(3):197-205.
5. Herring ME, Shah SK. Periodontal disease and control of diabetes mellitus. J Am Osteopath Assoc. 2006; 106(7):416-21, 2007;45(1):138-57.
6. Preshaw PM, Foster N, Taylor JJ. Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunological perspective. Periodontol 2000. 2007;45(1):138-57.
7. Soory M. Relevance of dyslipidaemia and its consequences in periodontal patients with co-existing cardiovascular disease and diabetes mellitus: Therapeutic targets. Rec Patents Endocr Metab Immune Drug Discov. 2009;3(3):214-24.
8. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008;79(6):979-86.
9. Soory M. Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management? Rheumatol: Res Rev. 2010;2:1-16.
10. Soory M. Oxidative Stress Induced Mechanisms in the Progression of Periodontal Diseases and Cancer: A Common Approach to Redox Homeostasis? Cancers. 2010;2(2):670-92.
11. Battino M, Bullon P, Wilson M, Newman H. Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med. 1999;10(4):458-76.
12. Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN, Battino M. Metabolic syndrome and periodontitis: Is oxidative stress a common link? J Dent Res. 2009;88(6):503-18.
13. Rahman ZA, Soory M. Antioxidant effects of glutathione and IGF in a hyperglycaemic cell culture model of fibroblasts: some actions of advanced glycaemic end products (AGE) and nicotine. Endocr Metab Immune Disord- Drug Targets. 2006;6(3):279-86.
14. Figuero-Ruiz, Soory M, Cerero R, Bascones A. Oxidant/antioxidant interactions of nicotine, Coenzyme Q10, Pycnogenol and phytoestrogens in oral periosteal fibroblasts and MG63 osteoblasts. Steroids. 2006;71(13-14): 1062-72.
15. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resístance, diabetes and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol. 2004;24(5):816-23.
16. Wright E, Scism-Bacon JL, Glass LC. Oxidative stress in type 2 diabetes: role of fasting and post-prandial glycaemia. Int J Clin Pract. 2006;60(3):308-14.
17. Kirkwood KL, Cirelli JA, Rogers JE, Giannobile WV. Novel host-response therapeutic approaches to treat periodontal diseases. Periodontol 2000. 2007;43(1):294-315.
18. Norse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol. 2008;35(8):668-73.
19. Demmer RT, Papapanou PN, Jacobs DR Jr, Desvarieux M. Evaluating clinical periodontal measures as surrogates for bacterial exposure: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). BMC Med Res Method. 2010;10:2(7 pages).
20. Demmer RT, Papapanou PN, Jacobs DR Jr, Desvarieux M. Bleeding on probing differentially relates to bacterial profiles: the Oral Infections and Vascular Disease Epidemiology Study. J Clin Periodontol. 2008;35(6):479-86.
21. Beck JD, Offenbacher S. Relationships among clinical measures of periodontal disease and their associations with systemic markers. Ann Periodontol. 2002;7(1):79-89.
22. Desvarieux M, Demmer RT, Rundek T, et al. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 2005;111(5):576-82.
23. Spahr A, Klein E, Khuseyinova N, et al. Periodontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the Coronary Event and Periodontal Disease (CORODONT) study. Arch Intern Med. 2006;166(5):554-9.
24. van Dyke TE, Dave S. Risk Factors for Periodontitis. J Int Acad Periodontol. 2005;7(1):3-7.
25. Kaysen GA. Biochemistry and biomarkers of inflamed patients: why look, what to assess. Clin J Am Soc Nephrol. 2009;4 Suppl 1:S56-S63.
26. Boesing F, Patiño JS, da Silva VR, Moreira EA. The interface between obesity and periodontitis with emphasis on oxidative stress and inflammatory response. Obes Rev. 2009;10(3):290-7.
27. Goodson JM, Groppo D, Halem S, Carpino E. Is obesity an oral bacterial disease? J Dent Res. 2009;88(6):519-23.
28. Yao Z, Yang J, Pan L, Chen Z. Periodontal treatment: potential to reduce cardiovascular morbidity and/or mortality. Med Hypotheses. 2009;73(1):33-5.
29. Uchida M, Shima M, Shimoaka T, et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol. 2000;185(2):207-14.
30. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol. 1998;160(1):403-9.
31. Crotti T, Smith MD, Hirsch R, et al. Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis. J Periodontal Res. 2003;38(4):380-7.
32. Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Medscape Womens Health. 2000;5(2):5.
33. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factorkappaB ligand and osteoprotegerin in bone cell biology. J Mol Med. 2001;79(5-6):243-53.
34. Cheng X, Kinosaki M, Murali R, Greene MI. The TNF receptor superfamily: role in immune inflammation and bone formation. Immunol Res. 2003;27(2-3):287-94.
35. Mahamed DA, Marleau A, Alnaeeli M, et al. G(-) anaerobes reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes. 2005;54(3):1477-86.
36. Teng YT, Nguyen H, Gao X, et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 2000;106:R59-67.
37. Kuula H, Salo T, Pirilä E, et al. Local and Systemic Responses in Matrix Metalloproteinase 8-Deficient Mice during Porphyromonas gingivalis- Induced Periodontitis. Infect Immun. 2009;77(2):850-9.
38. Omoigui, S. The Interleukin-6 inflammation pathway from cholesterol to aging-Role of statins, bisphosphonates and plant polyphenols in ageing and age-related diseases. Immun Ageing. 2007;4(2):1-22.
39. Gibson FC 3rd, Genco CA. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs. Curr Pharm Des. 2007;13(36):3665-75.
40. Onishi S, Honma K, Liang S, et al. Toll-like receptor 2-mediated interleukin- 8 expression in gingival epithelial cells by the Tannerella forsythia leucinerich repeat protein BspA. Infect Immun. 2008;76(1):198-205.
41. Krauss JL, Potempa J, Lambris JD, Hajishengallis G. Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontology 2000. 2010;52(1):141-62.
42. Ukai T, Yumoto H, Gibson FC 3rd, Genco CA. Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-a production. Infect Immun. 2008;76(2):812-9.
43. Kikkert R, Laine ML, Aarden LA, van Winkelhoff AJ. Activation of toll- like receptors 2 and 4 by gram-negative periodontal bacteria. Oral Microbiol Immunol. 2007;22(3):145-51.
44. Ruby J, Rehani K, Martin M. Treponema denticola activates mitogen- activated protein kinase signal pathways through Toll-like receptor 2. Infect Immun. 2007;75(12):5763-8.
45. Nussbaum G, Ben-Adi S, Genzler T, Sela M, Rosen G. TLR2 and TLR4 involvement in the innate immune response to Treponema denticola and its outer sheath components. Infect Immun. 2009;77(9):3939-47.
46. Goriely S, Neurath MF, Goldman M. How microorganisms tip the balance between interleukin-12 family members. Nat Rev Immunol. 2008;8(1):81-6.
47. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, van Dyke T, Banchereau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol. 2001;167(9):5067-76.
48. Gemmell E, Yamazaki K, Seymour GJ. The role of T cells in periodontal disease: homeostasis and autoimmunity. Periodontol 2000. 2007; 43(1):14-40.
49. Curtiss LK, Tobias PS. The toll of Toll-like receptors, especially tolllike receptor 2, on murine atherosclerosis. Curr Drug Targets. 2007; 8(12):1230-8.
50. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr. 2006;83(6):1237-1247; erratum in Am J Clin Nutr. 2006;84(5):1253.
51. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415-28.
52. Hansel B, Giral P, Nobecourt E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab. 2004;89(10):4963-71.
53. van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity. 2006;14(12):2127-31.
54. Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14(3-4):222-31.
55. Sonoki K, Nakashima S, Takata Y, et al. Decreased lipid peroxidation following periodontal therapy in type 2 diabetic patients. J Periodontol. 2006;77(11):1907-13.
56. Takeda M, Ojima M, Yoshioka H, et al. Relation of serum advanced glycation end products with deterioration of periodontitis in type 2 diabetic patients. J Periodontol. 2006;77(1):15-20.
57. Katz J, Bhattacharyya I, Farkhondeh-Kish F, Perez FM, Caudle RM, Heft MW. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol. 2005;32(1):40-4.
58. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C. Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors. J Clin Periodontol. 2004;31(1):25-9.
59. Trujillo ME, Scherer PE. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005;257(2):167-75.
60. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and Metabolic Syndrome. Arterioscler Thromb Vasc Biol. 2004;24(1):29-33.
61. Spranger J, Kroke A, Möhlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361(9353):226-8; erratum in Lancet. 2003;361:1060.
62. Yamaguchi N, Kukita T, Li YJ, et al. Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans. FEMS Immunol Med Microbiol. 2007;49(1):28-34.
63. Saito T, Yamaguchi N, Shimazaki Y, et al. Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res. 2008;87(4):319-22.
64. Baltacioglu E, Akalin FA, Alver A, Deger O, Karabulut E. Protein carbonyl levels in serum and gingival crevicular fluid in patients with chronic periodontitis. Arch Oral Biol. 2008;53(8):716-22.
65. Chapple IL, Milward MR, Dietrich T. The prevalence of inflammatory periodontitis is negatively associated with serum antioxidant concentrations. J Nutr. 2007;137(3):657-64.
66. Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett. 2005;10(2):255-64.
67. Baltacioglu E, Akalin FA, Alver A, Balaban F, Unsal M, Karabulut E. Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post-menopausal women with chronic periodontitis. J Clin Periodontol. 2006;33(6):385-92.
68. D'Aiuto F, Sabbah W, Netuveli G, et al. Association of the metabolic syndrome with severe periodontitis in a large U.S. population-based survey. J Clin Endocrinol Metab. 2008;93(10):3989-94.
69. Fentoglu O, Yesim Bozkurt FY. The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia. Eur J Dent. 2008;2(2):142-6.
70. Pischon N, Heng N, Bernimoulin JP, Kleber BN, Willich SN, Pischon T. Obesity, inflammation and periodontal diseases. J Dent Res. 2007; 86(5):400-9.
71. Saito T, Shimazaki Y. Metabolic disorders related to obesity and periodontal disease. Periodontology 2000. 2007;43(1):254-66.
72. Ritchie CS. Obesity and periodontal disease. Periodontol 2000. 2007; 44(1):154-63.
73. Mikhail N. The Metabolic Syndrome: Insulin Resistance. Curr Hypertens Reports. 2009;11(2):156-8.
74. Yamazaki K, Honda T, Domon H, et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol. 2007;149(3):445-52.
75. Mochari H, Grbic JT, Mosca L. Usefulness of Self-Reported Periodontal Disease to Identify Individuals with Elevated Inflammatory Markers at Risk of Cardiovascular Disease. Am J Cardiol. 2008;102(11):1509-13.
76. Linden GJ, McClean K, Young I, Evans A, Kee F. Persistently raised C- reactive protein levels are associated with advanced periodontal disease. J Clin Periodontol. 2008;35(9):741-7.
77. Desvarieux M, Demmer RT, Rundek T, et al. Relationship Between Periodontal Disease, Tooth Loss, and Carotid Artery Plaque: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke. 2003;34(9):2120-5.
78. Kraus VB, Stabler TV, Luta G, Renner JB, Dragomir AD, Jordan JM. Interpretation of Serum C-Reactive Protein (CRP) Levels for Cardiovascular Disease Risk is Complicated by Race, Pulmonary Disease, Body Mass Index, Gender, and Osteoarthritis. Osteoarthr Cartilage. 2007;15(8):966-71.
79. Behle JH, Sedaghatfar MH, Demmer RT, et al. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol. 2009;36(4):287-94.
80. Jain A, Batista EL Jr, Serhan C, Stahl GL, van Dyke TE. Role for Periodontitis in the Progression of Lipid Deposition in an Animal Model. Infect Immun. 2003;71(10):6012-18.
81. Tomar SL, Asma S. Smoking-attributable periodontitis in the United States; findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol. 2000;71(5):743-5l.
82. Kinane DF, Chestnutt IG. Relationship of diabetes to periodontitis. Curr Opin Periodontol. 1997;4(1):29-34.
83. Guzman S, Karima M, Wang HY, van Dyke TE. Association between interleukin- 1 genotype and periodontal disease in a diabetic population. J Periodontol. 2003;74(8):1183-90.
84. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Commun Dent Oral Epidemiol. 2002;30:(3):182-92.
85. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus:the role of tumor necrosis factoralpha in a 2-way relationship. J Periodontol. 2003;74(1):97-102.
86. Taylor GW. Bidirectional interrelationships. between diabetes, and periodontal diseases: an epidemiologic perspective. Ann Periodontol. 2001; 6(1):99-112.
87. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulindependent diabetes mellitus. J Periodontol. 1991;62(2):123-31.
88. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol. 1996;23(2):92-100.
89. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol. 1997;24(7):505-10.
90. Michalowicz BS, Diehl SR, Gunsolley JC, et al. Evidence of a substantial genetic basis for risk of adult periodontitis. J Periodontol. 2000;71(11):1699-707.
91. Dowsett SA, Archila I, Segreto VA, Eckert GJ, Kowolik MJ. Periodontal disease status of an indigenous population of Guatemala, Central America. J Clin Periodontol. 2001;28(7):663-71.
92. Ronderos M, Pihlstrom BL, Hodges JS. Periodontal disease among indigenous people in the Amazon rain forest. J Clin Periodontol. 2001;28(11):995-1003.
93. van Dyke TE, Serhan CN. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res. 2003;82(2):82-90.
94. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol. 2000;27(11):810-8.
95. Meisel P, Siegemund A, Grimm R, et al. The interleukin-1 polymorphism, smoking, and the risk of periodontal disease in the population-based SHIP study. J Dent Res. 2003;82(3):189-93.
96. Janket S.-J, Wightman A, Baird AE, van Dyke TE, Jones JA. Does Periodontal Treatment Improve Glycemic Control in Diabetic Patients? A Meta- analysis of Intervention Studies. J Dent Res. 2005;84(12):1154-9.
97. Nassar H, Kantarci A, van Dyke TE. Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000. 2007;43(1):233-44.
98. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two- way relationship. Ann Periodontol. 1998;3(1):51-61.
99. Karima M, Kantarci A, Ohira T, et al. Enhanced superoxide release and elevated protein Kinase C activity in neutrophil from diabetic patients: association with periodontitis. J Leukocyte Biol. 2005;78(4):862-70.
100. Nishimura S, Iwamoto Y, Soga Y. The periodontal host-response with diabetes. Periodontology 2000. 2007;43(1):245-53.
101. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28(1):27-32.
102. López-Bermejo A, Chico-Julià B, Castro A, et al. Alpha Defensins 1, 2, and 3 Potential Roles in Dyslipidemia and Vascular Dysfunction in Humans. Arterioscler Thromb Vasc Biol. 2007;27(5):1166.
103. Seymour RA. Is gum disease killing your patient? Br Dent J. 2009;206 (10):551-2.
104. Nagasawa T, Noda M, Katagiri S, et al. Relationship between periodontitis and diabetes-importance of a clinical study to prove the vicious cycle. Intern Med. 2010;49(10):881-5.
105. Demmer RT, Desvarieux M, Holtfreter B, et al. Periodontal status and A1C change: longitudinal results from the study of health in Pomerania (SHIP). Diabetes Care. 2010;33(5):1037-43.
106. Ohnishi T, Bandow K, Kakimoto K, Machigashira M, Matsuyama T, Matsuguchi T. Oxidative stress causes alveolar bone loss in metabolic syndrome model mice with type 2 diabetes. J Periodont Res. 2009;44(1):43-51.
107. Mazumdar V, Snitkin ES, Amar S, Segrè D. Metabolic network model of a human oral pathogen. J Bacteriol. 2009;191(1):74-90.
108. King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79 Suppl 8:1527-34.
109. Watanabe K, Petro BJ, Shlimon AE, Unterman TG. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats. J Periodontol. 2008;79(7):1208-16.
110. Nareika A, Maldonado A, He L, et al. High glucose-boosted inflammatory responses to lipopolysaccharide are suppressed by statin. J Periodont Res. 2007;42(1):31-8.
111. Fruchart J, Staels B, Duriez P. PPARs, metabolic disease and atherosclerosis. Pharmacol Res. 2001;44(5):345-52.
112. Neve BP, Fruchart J, Staels B. Role of the PPAR in atherosclerosis. Biochem Pharmacol. 2000;60(8):1245-50.
113. Yamada S, Yanagawa T, Sasamoto K, Araki A, Miyao M, Yamanouchi T. Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients. Metabolism. 2006;55(1):67-71.
114. Takebayashi K, Matsumoto S, Wakabayashi S, et al. The effect of lowdose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia. Metabolism. 2005;54(9):1225-9.
115. Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Met. 2004;89(2): 740-7.
116. Soory M. Redox status in periodontal and systemic inflammatory conditions including associated neoplasias: Antioxidants as adjunctive therapy? Infect Disord-Drug Targets (Supplement on Redox status in the pathophysiology of inflammation and therapeutic targets). 2009;9(4):415-27.
117. Soory M. Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: Potential for therapeutic targeting. Infect Disord -Drug Targets (Supplement on Redox status in the pathophysiology of inflammation and therapeutic targets). 2009;9(4):400-14.
118. Palmer RM, Soory M. Chapter 5: Modifying factors; Diabetes, Pregnancy and Smoking in the Textbook of Clinical Periodontology and Implant Dentistry (Editors: Lindhe, Lang and Karring. 5th Edition, 2008; Blackwell Munksgaard.
119. Eley BM, Soory M, Manson D. Chapter 6: The effect of systemic factors on the periodontal tissues. Periodontics 6th Edition 2010; Elsevier.
120. Paju S, Sinisalo J, Pussinen PJ, Valtonen V, Nieminen MS. Is periodontal infection behind the failure of antibiotics to prevent coronary events? Atherosclerosis. 2007;193(1):193-95.
121. Soory M. A role for non-antimicrobial actions of tetracyclines in combating oxidative stress in periodontal and metabolic diseases, Open Dent J. 2008;2(1):5-12.
122. Bahekar AA, Singh S, Saha S, et al. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta- analysis. Am Heart J. 2007;154(5):830-7.
123. Pussinen PJ, Mattila K. Periodontal infections and atherosclerosis: mere associations? Curr Opin Lipidol. 2004;15(5):583-8.
124. Oorni K, Kovanen PT. Proteolysis of low density lipoprotein particles by Porphyromonas gingivalis microorganisms: a novel biochemical link between periodontitis and cardiovascular diseases? J Int Med. 2008;263(5):553-7.
125. Pussinen PJ, Tuomisto K, Jousilahti P, et al. Endotoxaemia, immune response to periodontal pathogens and systemic inflammation associated with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007;27(6):1433-9.
126. Elkaim R, Dahan M, Kocgozlu L, et al. Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: A preliminary study. J Periodont Res. 2008;43(2):224-31.
127. van Leuven SI, Franssen R, Kastelein JJ, et al. Systemic inflammation as a risk factor for atherothrombosis. Rheumatology. 2008;47(1):3-7.
128. Buhlin K, Hultin M, Norderyd O, et al. Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis. 2009;206(2):518-22.
129. Pussinen PJ, Malle E, Metso J, et al. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis. 2001;155(2):297-305.
130. Pussinen PJ, Jauhiainen M, Vikuna-Rautiainen T, et al. Periodontitis decreases the anti-atherogenic potency of high density lipoprotein. J Lipid Res. 2004;45(1):139-47.
131. Papapanou PN, Sedaghatfar MH, Demmer RT, et al. Periodontal therapy alters gene expression of peripheral blood monocytes. J Clin Periodontol. 2007;34(9):736-47.
132. Parker B, Bruce IN. The metabolic syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am. 2010;36(1):81-97.
133. Reddi D, Bostanci N, Hashim A, et al. Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. Microbes Infect. 2008;10(14-15):1459-68.
134. Sanz M, D'Aiuto F, Deanfield J, Fernandez-Aviles F. European workshop in periodontal health and cardiovascular disease-scientific evidence on the association between periodontal and cardiovascular diseases: a review of the literature. Eur Heart J Suppl. 2010;12 Suppl B:B3-B12.
135. Iacopino AM. Periodontitis and Diabetes Interrelationships: Role of inflammation. Ann Periodontol. 2001;6(1):125-37.
136. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol. 2008;79 Suppl 8:1544-51.